{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T20:09:10Z","timestamp":1788725350564,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114\\u20132628-B-038\\u2013008-MY3"],"award-info":[{"award-number":["114\\u20132628-B-038\\u2013008-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["115\\u20132320-B-038\\u2013004"],"award-info":[{"award-number":["115\\u20132320-B-038\\u2013004"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["W115FRP-04"],"award-info":[{"award-number":["W115FRP-04"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["DP2-TMU-115-C-01"],"award-info":[{"award-number":["DP2-TMU-115-C-01"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018493","name":"Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["111TMU-SHH-31"],"award-info":[{"award-number":["111TMU-SHH-31"]}],"id":[{"id":"10.13039\/100018493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018493","name":"Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["113TMU-SHH-31"],"award-info":[{"award-number":["113TMU-SHH-31"]}],"id":[{"id":"10.13039\/100018493","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118415","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:12:18Z","timestamp":1788361938000},"page":"118415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["KDM1A\/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin"],"prefix":"10.1016","volume":"254","author":[{"given":"An-Chih","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5124-0643","authenticated-orcid":false,"given":"Jian-Ying","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jr-Jiun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica Angelina","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hsiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Wei","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-I","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ping","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-5472","authenticated-orcid":false,"given":"Wei-Lun","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118415_b0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1477-7819-10-220","article-title":"Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields","volume":"10","author":"Rulseh","year":"2012","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0010","first-page":"17","article-title":"Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review","volume":"4","author":"Singh","year":"2021","journal-title":"Cancer Drug Resist."},{"issue":"10","key":"10.1016\/j.bcp.2026.118415_b0015","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41419-021-04182-w","article-title":"Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bcp.2026.118415_b0020","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1038\/oncsis.2017.31","article-title":"Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma","volume":"6","author":"Chuang","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bcp.2026.118415_b0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbrc.2021.02.140","article-title":"Correlation between the expression of cancer stem cell marker BMI1 and glioma prognosis","volume":"550","author":"Tsai","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2026.118415_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040981","article-title":"Betulinic acid-mediated tuning of PERK\/CHOP signaling by Sp1 inhibition as a novel therapeutic strategy for glioblastoma","volume":"12","author":"Lo","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.118415_b0035","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2147\/CMAR.S186142","article-title":"The unique invasiveness of glioblastoma and possible drug targets on extracellular matrix","volume":"11","author":"Hatoum","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bcp.2026.118415_b0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2017.11.010","article-title":"Glioma epigenetics: from subclassification to novel treatment options","volume":"51","author":"Gusyatiner","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118415_b0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.molcel.2021.12.004","article-title":"Now open: evolving insights to the roles of lysine acetylation in chromatin organization and function","volume":"82","author":"Chen","year":"2022","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40364-025-00788-w","article-title":"Epigenetic regulation of histone modifications in glioblastoma: recent advances and therapeutic insights","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomark Res"},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12929-016-0296-6","article-title":"Suberoylanilide hydroxamic acid represses glioma stem-like cells","volume":"23","author":"Hsu","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bcp.2026.118415_b0060","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noaa103","article-title":"Increased activation of HDAC1\/2\/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma","author":"Yang","year":"2020","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0065","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","article-title":"Epigenetics-targeted drugs: current paradigms and future challenges","volume":"9","author":"Dai","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41392-020-00252-1","article-title":"The role of histone methylation in the development of digestive cancers: a potential direction for cancer management","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2026.118415_b0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ng1966","article-title":"Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome","volume":"39","author":"Heintzman","year":"2007","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bcp.2026.118415_b0080","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","article-title":"Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bcp.2026.118415_b0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: a dynamic mark in health, disease and inheritance","volume":"13","author":"Greer","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.bcp.2026.118415_b0090","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.cell.2018.10.006","article-title":"N(6)-methyladenine DNA modification in glioblastoma","volume":"175","author":"Xie","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118415_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1144184","article-title":"The function of histone methylation and acetylation regulators in GBM pathophysiology","volume":"13","author":"McCornack","year":"2023","journal-title":"Front. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.118415_b0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11010-014-2077-4","article-title":"Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells","volume":"394","author":"Tao","year":"2014","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12929-021-00737-3","article-title":"Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases","volume":"28","author":"Kim","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bcp.2026.118415_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1120911","article-title":"LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials","volume":"14","author":"Noce","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118415_b0115","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/neuonc\/noad018","article-title":"Lysine-specific histone demethylase 1A (KDM1A\/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma","volume":"25","author":"Alejo","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bcp.2026.118415_b0120","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.redox.2017.08.005","article-title":"Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O(6)-methylguanine-DNA methyltransferase","volume":"13","author":"Chang","year":"2017","journal-title":"Redox Biol."},{"issue":"W1","key":"10.1016\/j.bcp.2026.118415_b0125","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese glioma genome atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/neuonc\/now247","article-title":"GlioVis data portal for visualization and analysis of brain tumor expression datasets","volume":"19","author":"Bowman","year":"2017","journal-title":"Neuro Oncol."},{"issue":"24","key":"10.1016\/j.bcp.2026.118415_b0140","doi-asserted-by":"crossref","first-page":"17824","DOI":"10.1021\/acs.jmedchem.1c00966","article-title":"Installation of pargyline, a LSD1 inhibitor, in the HDAC inhibitory template culminated in the identification of a tractable antiprostate cancer agent","volume":"64","author":"Ojha","year":"2021","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118415_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092444","article-title":"ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays","volume":"9","author":"Guzman","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bcp.2026.118415_b0150","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bcp.2026.118415_b0155","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/j.ymthe.2021.10.028","article-title":"FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9\/CYLD\/NF-kappaB axis","volume":"30","author":"Chen","year":"2022","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2026.118415_b0160","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41588-025-02167-5","article-title":"The multilayered transcriptional architecture of glioblastoma ecosystems","volume":"57","author":"Nomura","year":"2025","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bcp.2026.118415_b0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10555-023-10114-1","article-title":"The role of histone H3 lysine demethylases in glioblastoma","volume":"42","author":"Young","year":"2023","journal-title":"Cancer Metastasis Rev."},{"issue":"22","key":"10.1016\/j.bcp.2026.118415_b0170","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167081","article-title":"Quisinostat is a brain-penetrant radiosensitizer in glioblastoma","volume":"8","author":"Lo Cascio","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41576-024-00761-7","article-title":"Chromosomal instability as a driver of cancer progression","volume":"26","author":"Chen","year":"2025","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-024-01767-7","article-title":"The two sides of chromosomal instability: drivers and brakes in cancer","volume":"9","author":"Hosea","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7793","key":"10.1016\/j.bcp.2026.118415_b0185","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1913-9","article-title":"Patterns of somatic structural variation in human cancer genomes","volume":"578","author":"Li","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2026.118415_b0190","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf1517","article-title":"Linking kinetochore attachment to checkpoint control: the role of Aurora B in BubR1 acetylation","volume":"54","author":"Choi","year":"2026","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118415_b0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41419-021-03405-4","article-title":"Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0200","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s40001-024-02182-y","article-title":"SPAG5 is a potential therapeutic target affecting proliferation, apoptosis, and invasion of esophageal cancer cells","volume":"29","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0205","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1038\/s41467-018-07664-2","article-title":"Microtubule asters anchored by FSD1 control axoneme assembly and ciliogenesis","volume":"9","author":"Tu","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2026.118415_b0210","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41417-024-00824-1","article-title":"Identification of KIFC1 as a putative vulnerability in lung cancers with centrosome amplification","volume":"31","author":"Zhang","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41392-020-00396-0","article-title":"Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers","volume":"6","author":"Liu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2026.118415_b0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00412-016-0607-4","article-title":"Aurora a, MCAK, and Kif18b promote Eg5-independent spindle formation","volume":"126","author":"van Heesbeen","year":"2017","journal-title":"Chromosoma"},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40001-025-03648-3","article-title":"MYBL2 regulates the expression of CENPF in lung adenocarcinoma and promotes tumor development and metastasis through AKT pathway activation","volume":"31","author":"Liu","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"38","key":"10.1016\/j.bcp.2026.118415_b0230","doi-asserted-by":"crossref","first-page":"35140","DOI":"10.1074\/jbc.M205503200","article-title":"Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclins","volume":"277","author":"Fung","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2026.118415_b0235","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1158\/1078-0432.CCR-24-3571","article-title":"Myt1 Kinase: an emerging cell-cycle regulator for cancer therapeutics","volume":"31","author":"Lang","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.bcp.2026.118415_b0240","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1093\/emboj\/cdf567","article-title":"Regulation of G(2)\/M events by Cdc25A through phosphorylation-dependent modulation of its stability","volume":"21","author":"Mailand","year":"2002","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.bcp.2026.118415_b0245","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s12276-020-00542-2","article-title":"LSD1: more than demethylation of histone lysine residues","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118415_b0250","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41420-023-01502-1","article-title":"Targeting lysine-specific demethylase 1 (KDM1A\/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation","volume":"9","author":"Antona","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bcp.2026.118415_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.700947","article-title":"Characterization of histone deacetylase mechanisms in cancer development","volume":"11","author":"Hai","year":"2021","journal-title":"Front. Oncol."},{"issue":"18","key":"10.1016\/j.bcp.2026.118415_b0260","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.devcel.2025.04.022","article-title":"Neurodevelopmental hijacking of oligodendrocyte lineage programs drives glioblastoma infiltration","volume":"60","author":"Wu","year":"2025","journal-title":"Dev. Cell"},{"issue":"16","key":"10.1016\/j.bcp.2026.118415_b0265","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","article-title":"Glioblastoma hijacks neuronal mechanisms for brain invasion","volume":"185","author":"Venkataramani","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118415_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.588476","article-title":"Early life stress- and drug-induced histone modifications within the ventral tegmental area","volume":"8","author":"Shepard","year":"2020","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T19:38:31Z","timestamp":1788723511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226007549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":54,"alternative-id":["S0006295226007549"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118415","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KDM1A\/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118415"}}